prof. Nicolaas Lumen (MD, PhD)

CRIG group leader
Nicolaas Lumen


Head of clinic - urology (UZ Gent)
Associate professor (Faculty of Medicine and Health Sciences)
Principal investigator of clinical studies in uro-oncology

 

Research focus

  • Role of the androgen receptor in the development of castration-refractory prostate cancer
  • Role of exosomes in plasma en urine in prostate cancer
  • Role of cytoreductive prostatectomy in metastatic prostate cancer

We try to understand why cancer treatment fails in some patients and works well in other patients. By understanding this, we hope to identify markers in blood and/or urine to select the best treatment strategy for each individual patient
 

Biography

  • University: Ghent University, Faculty of Medicine and Health Sciences
    • Graduated as Medical Doctor with the Greatest Honour at 28/6/2002
  • Training in Urology:
    • General Surgery: O.L.V.-Van Lourdes Kliniek Waregem, 1/08/2002-31/07/2004
    • Urology: Universitair Ziekenhuis Gent, 1/08/2004-31/7/2008
    • Fellowship robotic and laparoscopic urology: O.L.V.-Ziekenhuis Aalst, 1/8/2008-31/1/2009
    • Certified as Urologist since 1/8/2008
  • Additional qualifications
    • Principles of electrocardiography (2002)
    • Principles of radiation physics and radiation protection (2002)
    • Emergency medicine (2005)
    • Fellow of the European Board of Urology (written examination Prague 2007; oral examination Athens 2008)
  • Current status
    • Member of Staf Urology, Universitair ziekenhuis Gent 
    • Chairman of the European Association of Urology urethral stricture guidelines panel
    • Member of the European Society of Genito-Urinary Reconstructive Surgeons (ESGURS)
    • Professor in Urology (hoofddocent) at the Faculty of Medicine and Health Sciences, University of Ghent
    • Expert for KCE and Hoge Raad voor Gezondheidszorg
    • Medisch Majoor bij de Medische Component van Defensie
  • Doctor in Medical Sciences with dissertation (Ph.D.) "Optimising treatment of male urethral stricture disease." (10-3-2010)
     

Research team

Contact

uro-oncology, UZ Gent 1B2